Neuland Laboratories Stock Price: Pharma company Newland Laboratories shares have a tremendous rise on Monday, 14 July. In the day, the stock on BSE went up to 20 percent to a high of Rs 14767.20. At the end of the trading, the stock was up 18.6 percent to settle at Rs 14601.10. The company’s shareholders are going to get a final dividend of Rs 12 per share for FY 2024-25. The record date for this is 18 July 2025.
By this date, shareholders whose names will be in the records of the Register of Members of the Company or Depositors as the beneficiaries owners of shares will be entitled to dividend. It is estimated that this is the main reason for increasing the purchase in the stock. The company gave a final dividend of Rs 14 per share for FY 2024.
The market cap of Newland Laboratories is Rs 18700 crore. The face value of the stock is Rs 10. The company had 32.68 percent stake in the company till the end of March 2025. The stock is included in the portfolio of veteran investors Vijay Kedia and Mukul Aggarwal.
In the last 2 years, Newland Laboratories shares have climbed 392 percent, 80 percent in 1 year and 24 percent in a week. At the same time, it has seen a rise of about 2200 percent in 5 years. The 52 -week high level of the stock is Rs 18,089.55, which was created on 4 December 2024. The 52 -week low of Rs 7,900 was seen on 23 July 2024. In May, global brokerage firm Goldman Sachs gave a target price of Rs 14775 per share with a ‘bye’ rating for the stock.
Profit in March quarter Rs 28 crore
Newland Laboratories’ revenue was Rs 328.36 crore on the standalone basis in the January-March 2025 quarter. Meanwhile, net profit was recorded at Rs 27.73 crore and Earnings Rs 21.62 crore per share. During the entire financial year 2024-25, the revenue was Rs 1,476.84 crore, net profit of Rs 259.43 crore and earnings per share was Rs 202.20 crore. Financial results of the company’s April-June 2025 quarter will be announced after the board meeting on 31 July.
Disclaimer: Advice or idea experts/brokerage firms given on Moneycontrol.com have their own personal views. The website or management is not responsible for this. Moneycontrol advises to users that always seek the advice of certified experts before taking any investment decision.